Bio-Techne News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH Branche:  Biotechnologie Land:  USA
50,86 $
-0,63 $
-1,22%
44,424 € 13.03.26
Depot/Watchlist
Marktkapitalisierung *
7,89 Mrd. €
Streubesitz
-
KGV
109,47
Dividende
0,29 EUR
Dividendenrendite
0,57%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Bio-Techne News

15.10.25 - PR Newswire
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
Bio-​Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results PR Newswire
09.10.25 - PR Newswire
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
Bio-​Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 PR Newswire
26.09.25 - PR Newswire
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
Bio-​Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications PR Newswire
24.09.25 - PR Newswire
Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
Bio-​Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report PR Newswire
09.09.25 - PR Newswire
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California PR Newswire
27.08.25 - PR Newswire
Bio-Techne to Present at Upcoming Investor Conferences
Bio-​Techne to Present at Upcoming Investor Conferences PR Newswire
14.08.25 - PR Newswire
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory PR Newswire
06.08.25 - PR Newswire
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
Bio-​Techne Releases Fourth Quarter Fiscal 2025 Results PR Newswire
06.08.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND
BIO-​TECHNE DECLARES DIVIDEND PR Newswire
05.08.25 - PR Newswire
Bio-Techne Announces Exosome Diagnostics Divestiture
Bio-​Techne Announces Exosome Diagnostics Divestiture PR Newswire
05.08.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine PR Newswire
31.07.25 - PR Newswire
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering PR Newswire
17.07.25 - PR Newswire
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
Bio-​Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results PR Newswire
15.07.25 - PR Newswire
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
Bio-​Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection PR Newswire
14.07.25 - PR Newswire
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Bio-​Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-​Based Gene Therapy PR Newswire
04.07.25 - LYNX Analysen
Bio-Techne: Innovation, Expansion und ein möglicher Kursausbruch
Bio-​Techne könnte vor einem Wachstumsschub stehen. Bisher wird das nicht nur ignoriert, sondern mit einem Kurssturz quittiert. Jetzt vollständige Analyse lesen
24.06.25 - PR Newswire
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
Bio-​Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development PR Newswire
10.06.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics PR Newswire
29.05.25 - PR Newswire
Bio-Techne to Present at Investor Conferences
Bio-​Techne to Present at Investor Conferences PR Newswire
14.05.25 - PR Newswire
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) PR Newswire

Newssuche

Videos

newspaper
13.03.26 -3,08%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »